Seed Health and Axial Therapeutics announced a joint development program targeting the microbiome-gut-brain axis for mental health, with the potential...
Read more
Axial Therapeutics announced that A. Stewart Campbell, Ph.D., chief executive officer, will participate in a panel titled “Placing Patients...
Read more
Axial Therapeutics announced that its scientific founder and California Institute of Technology (Caltech) Professor, Sarkis Mazmanian, Ph.D., will be...
Read more
Axial Therapeutics announced the publication of preclinical research demonstrating that microbial metabolites produced by gut bacteria commonly found in...
Read more
Axial Therapeutics announced the publication in Nature Medicine of full results from its Phase 1b/2a clinical trial of AB-2004....
Read more
Axial Therapeutics announced that management will participate in a fireside chat at the 2020 RBC Capital Markets Healthcare Private...
Read more
Axial Biotherapeutics announced a $440,000 grant from the Michael J. Fox Foundation for Parkinson’s Research to support its efforts...
Read more
Kairos Ventures portfolio company Axial Biotherapeutics announced the appointment of Dr. Gregory T. Bates as Senior Vice President of...
Read more
We're excited to share that our portfolio company, Axial Biotherapeutics, has been selected as one of FierceBiotech's Fierce 15...
Read more
This month, Axial Biotherapeutics announced the appointment of leading experts in the Autism Spectrum Disorders (ASD) field to its...
Read more